US Patent 9139653 Anti-human OX40L antibodies and methods of treatment
Patent 9139653 was granted and assigned to Kymab on September, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+106 characters)
Article
Patent abstract
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09139653 Anti-human OX40L antibodies and methods of treatment US Patent 9139653 Anti-human OX40L antibodies and methods of treatment
Infobox
Patent Number
09139653
Patent Number
9139653
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09139653 Anti-human OX40L antibodies and methods of treatment
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09139653
Date of patent
September 22, 2015
Patent application number
14700896
Date Filed
April 30, 2015
Patent primary examiner
Find more entities like US Patent 9139653 Anti-human OX40L antibodies and methods of treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
